{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:43:51Z","timestamp":1787510631003,"version":"build-2736575974"},"reference-count":88,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["NIAAA AA021883, NIAAA AA021788, NIAAA AA021891, NIAAA U01 AA021840, UH2\/UH3AA026218"],"award-info":[{"award-number":["NIAAA AA021883, NIAAA AA021788, NIAAA AA021891, NIAAA U01 AA021840, UH2\/UH3AA026218"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1035237"],"award-info":[{"award-number":["OPP1035237"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Alcoholic hepatitis (AH) is characterized by intense systemic and liver inflammation, posing significant risks of health complications and mortality. While inflammation is a crucial defense mechanism against injury and infection, its timely resolution is essential to prevent tissue damage and restore tissue homeostasis. The resolution of inflammation is primarily governed by specialized pro-resolving mediators (SPMs), lipid metabolites derived from w-6 and w-3 poly-unsaturated fatty acids (PUFAs). Currently, the balance between pro-inflammatory lipid mediators (PLMs) and SPMs in the w-6 and w-3 PUFA metabolic pathways and the impact of alcohol abstinence on profiles of PLMs and SPMs in AH patients are not well studied.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this study, we used LC-MS\/MS and ELISA to quantify levels of lipid mediators (LMs) and their precursors in the plasma samples from 58 AH patients, 29 heavy drinkers without overt liver diseases (HDCs), and 35 healthy controls (HCs). Subsequently, we assessed correlations of altered LMs with clinical parameters and inflammatory mediators. Furthermore, we conducted a longitudinal study to analyze the effects of alcohol abstinence on LMs over 6- and 12-month follow-ups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>AH patients exhibited significantly higher plasma levels of w-6 PLMs (PGD2 and LTB4) and SPM RvE1 compared to HDCs or HCs. Conversely, the SPM LXA4 was significantly downregulated in AH patients. Some of these altered LMs were found to correlate with AH disease severity and various inflammatory cytokines. Particularly, the LTB4\/LXA4 ratio was substantially elevated in AH patients relative to HDCs and HCs. This altered ratio displayed a positive correlation with the MELD score. Importantly, the majority of dysregulated LMs, particularly PLMs, were normalized following alcohol abstinence.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2024.1377236","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:10:11Z","timestamp":1732147811000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Disrupted balance between pro-inflammatory lipid mediators and anti-inflammatory specialized pro-resolving mediators is linked to hyperinflammation in patients with alcoholic hepatitis"],"prefix":"10.3389","volume":"15","author":[{"given":"Wei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun J.","family":"Sanyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay H.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naga P.","family":"Chalasani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qigui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,11,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/biom5032023","article-title":"Alcoholic liver disease: role of cytokines","volume":"5","author":"Neuman","year":"2015","journal-title":"Biomolecules"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2011.07003.x","article-title":"Hepatoprotective and anti-inflammatory cytokines in alcoholic liver disease","author":"Gao","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/acer.12558","article-title":"Stratification of risk of death in severe acute alcoholic hepatitis using a panel of adipokines and cytokines","volume":"38","author":"Rachakonda","year":"2014","journal-title":"Alcohol Clin Exp Res"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29242","article-title":"Alcohol abstinence ameliorates the dysregulated immune profiles in patients with alcoholic hepatitis: A prospective observational study","volume":"66","author":"Li","year":"2017","journal-title":"Hepatology"},{"key":"B5","article-title":"Alcoholic liver disease: pathogenesis and current management","volume":"38","author":"Osna","year":"2017","journal-title":"Alcohol Res"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i42.11904","article-title":"Immune dysfunction in acute alcoholic hepatitis","volume":"21","author":"Dhanda","year":"2015","journal-title":"World J Gastroenterol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00236.2013","article-title":"Ethanol disrupts intestinal epithelial tight junction integrity through intracellular calcium-mediated Rho\/ROCK activation","volume":"306","author":"Elamin","year":"2014","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/01.alc.0000189280.19073.28","article-title":"Activation of the innate immune system and alcoholic liver disease: effects of ethanol per se or enhanced intestinal translocation of bacterial toxins induced by ethanol","volume":"29","author":"Bode","year":"2005","journal-title":"Alcohol Clin Exp Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.09.002","article-title":"Alcoholic liver disease: pathogenesis and new therapeutic targets","volume":"141","author":"Gao","year":"2011","journal-title":"Gastroenterology"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/acer.14331","article-title":"Persistent hyperactivation of endothelial cells in patients with alcoholic hepatitis","volume":"44","author":"Xia","year":"2020","journal-title":"Alcohol Clin Exp Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/acer.14579","article-title":"Blood biomarkers of intestinal epithelium damage regenerating islet-derived protein 3alpha and trefoil factor 3 are persistently elevated in patients with alcoholic hepatitis","volume":"45","author":"Yang","year":"2021","journal-title":"Alcohol Clin Exp Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29623","article-title":"The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis","volume":"67","author":"Puri","year":"2018","journal-title":"Hepatology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2020.100220","article-title":"Gut dysbiosis as a driver in alcohol-induced liver injury","volume":"3","author":"Fairfield","year":"2021","journal-title":"JHEP Rep"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-nutr-072610-145138","article-title":"Inflammation in alcoholic liver disease","volume":"32","author":"Wang","year":"2012","journal-title":"Annu Rev Nutr"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a016311","article-title":"Lipid mediators in the resolution of inflammation","volume":"7","author":"Serhan","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.tips.2018.01.003","article-title":"Specialized proresolving mediators: enhancing nonalcoholic steatohepatitis and fibrosis resolution","volume":"39","author":"Musso","year":"2018","journal-title":"Trends Pharmacol Sci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1021\/cr100396c","article-title":"Resolvins and protectins in inflammation resolution","volume":"111","author":"Serhan","year":"2011","journal-title":"Chem Rev"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20110327","article-title":"Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution","volume":"437","author":"Fredman","year":"2011","journal-title":"Biochem J"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10101627","article-title":"Omega-3 polyunsaturated fatty acids (PUFAs): emerging plant and microbial sources, oxidative stability, bioavailability, and health benefits-A review","volume":"10","author":"Saini","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12859","article-title":"An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques","volume":"7","author":"Fredman","year":"2016","journal-title":"Nat Commun"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1410851111","article-title":"Resolvin D1 limits 5-lipoxygenase nuclear localization and leukotriene B4 synthesis by inhibiting a calcium-activated kinase pathway","volume":"111","author":"Fredman","year":"2014","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2133253100","article-title":"Nuclear localization of 5-lipoxygenase as a determinant of leukotriene B4 synthetic capacity","volume":"100","author":"Luo","year":"2003","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2007.06.002","article-title":"5-Lipoxygenase: regulation of expression and enzyme activity","volume":"32","author":"Radmark","year":"2007","journal-title":"Trends Biochem Sci"},{"key":"B24","article-title":"Resolvins: Current understanding and future potential in the control of inflammation","volume":"12","author":"Bannenberg","year":"2009","journal-title":"Curr Opin Drug Discovery Devel"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.prostaglandins.2004.03.005","article-title":"Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis","volume":"73","author":"Serhan","year":"2004","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1097\/00075197-200503000-00003","article-title":"Novel eicosanoid and docosanoid mediators: resolvins, docosatrienes, and neuroprotectins","volume":"8","author":"Serhan","year":"2005","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"B27","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.chembiol.2012.11.010","article-title":"Resolvin D3 and aspirin-triggered resolvin D3 are potent immunoresolvents","volume":"20","author":"Dalli","year":"2013","journal-title":"Chem Biol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M045583","article-title":"Short-term n-3 fatty acid supplementation but not aspirin increases plasma proresolving mediators of inflammation","volume":"55","author":"Barden","year":"2014","journal-title":"J Lipid Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2012.190199","article-title":"Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation","volume":"58","author":"Mas","year":"2012","journal-title":"Clin Chem"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M047357","article-title":"Dietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathway","volume":"55","author":"Fischer","year":"2014","journal-title":"J Lipid Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.117.312472","article-title":"Impaired production and diurnal regulation of vascular rvD(n-3 DPA) increase systemic inflammation and cardiovascular disease","volume":"122","author":"Colas","year":"2018","journal-title":"Circ Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055859","article-title":"Proresolution lipid mediators in multiple sclerosis - differential, disease severity-dependent synthesis - a clinical pilot trial","volume":"8","author":"Pruss","year":"2013","journal-title":"PloS One"},{"key":"B33","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nri.2015.4","article-title":"Specialized pro-resolving mediators: endogenous regulators of infection and inflammation","volume":"16","author":"Basil","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.02.009","article-title":"Proresolving lipid mediators and mechanisms in the resolution of acute inflammation","volume":"40","author":"Buckley","year":"2014","journal-title":"Immunity"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2013.05.012","article-title":"Resolution phase lipid mediators of inflammation: agonists of resolution","volume":"13","author":"Serhan","year":"2013","journal-title":"Curr Opin Pharmacol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/emmm.201201891","article-title":"Toll-like receptor 7 stimulates production of specialized pro-resolving lipid mediators and promotes resolution of airway inflammation","volume":"5","author":"Koltsida","year":"2013","journal-title":"EMBO Mol Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/nri2294","article-title":"Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators","volume":"8","author":"Serhan","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1084\/jem.192.8.1197","article-title":"Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing","volume":"192","author":"Serhan","year":"2000","journal-title":"J Exp Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20020760","article-title":"Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals","volume":"196","author":"Serhan","year":"2002","journal-title":"J Exp Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/nature05877","article-title":"Resolvin E1 and protectin D1 activate inflammation-resolution programmes","volume":"447","author":"Schwab","year":"2007","journal-title":"Nature"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201343316","article-title":"Lipoxin A(4) modulates adaptive immunity by decreasing memory B-cell responses via an ALX\/FPR2-dependent mechanism","volume":"44","author":"Ramon","year":"2014","journal-title":"Eur J Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1096\/fj.11-201442","article-title":"Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain","volume":"26","author":"Serhan","year":"2012","journal-title":"FASEB J"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/2380319","article-title":"Maresins: specialized proresolving lipid mediators and their potential role in inflammatory-related diseases","volume":"2018","author":"Tang","year":"2018","journal-title":"Mediators Inflammation"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00487.x","article-title":"Lipoxins: potential anti-inflammatory, proresolution, and antifibrotic mediators in renal disease","volume":"65","author":"Kieran","year":"2004","journal-title":"Kidney Int"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-11-122598","article-title":"Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets","volume":"112","author":"Dona","year":"2008","journal-title":"Blood"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2016.10.004","article-title":"Treatment of alcohol use disorder in patients with alcoholic liver disease","volume":"130","author":"Leggio","year":"2017","journal-title":"Am J Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1016\/j.cgh.2016.05.041","article-title":"Effects of age, sex, body weight, and quantity of alcohol consumption on occurrence and severity of alcoholic hepatitis","volume":"14","author":"Liangpunsakul","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00024.2014","article-title":"Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue","volume":"307","author":"Colas","year":"2014","journal-title":"Am J Physiol Cell Physiol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nature13479","article-title":"Pro-resolving lipid mediators are leads for resolution physiology","volume":"510","author":"Serhan","year":"2014","journal-title":"Nature"},{"key":"B50","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.plefa.2017.01.004","article-title":"Identification and profiling of specialized pro-resolving mediators in human tears by lipid mediator metabolomics","volume":"117","author":"English","year":"2017","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000052","article-title":"Alcohol abstinence does not fully reverse abnormalities of mucosal-associated invariant T cells in the blood of patients with alcoholic hepatitis","volume":"10","author":"Li","year":"2019","journal-title":"Clin Transl Gastroenterol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-015-8852-6","article-title":"Advances in liquid chromatography-high-resolution mass spectrometry for quantitative and qualitative environmental analysis","volume":"407","author":"Acena","year":"2015","journal-title":"Anal Bioanal Chem"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00160","article-title":"Resolution of inflammation: what controls its onset","volume":"7","author":"Sugimoto","year":"2016","journal-title":"Front Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1172\/JCI124615","article-title":"The role of macrophages in the resolution of inflammation","volume":"129","author":"Watanabe","year":"2019","journal-title":"J Clin Invest"},{"key":"B55","article-title":"The dual roles of neutrophils and macrophages in inflammation: a critical balance between tissue damage and repair","volume":"41","author":"Butterfield","year":"2006","journal-title":"J Athl Train"},{"key":"B56","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jhep.2022.08.029","article-title":"Neutrophil extracellular traps contribute to liver damage and increase defective low-density neutrophils in alcohol-associated hepatitis","volume":"78","author":"Cho","year":"2023","journal-title":"J Hepatol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.MCHD-0035-2016","article-title":"Lipid mediators in inflammation","volume":"4","author":"Bennett","year":"2016","journal-title":"Microbiol Spectr"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02993","article-title":"New insights on the role of lipid metabolism in the metabolic reprogramming of macrophages","volume":"10","author":"Batista-Gonzalez","year":"2019","journal-title":"Front Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202255664","article-title":"Local and systemic effects of microbiome-derived metabolites","volume":"23","author":"Spivak","year":"2022","journal-title":"EMBO Rep"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27154836","article-title":"Specialized pro-resolving mediators in neuroinflammation: overview of studies and perspectives of clinical applications","volume":"27","author":"Valente","year":"2022","journal-title":"Molecules"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1172\/JCI97947","article-title":"Pro-resolving lipid mediators in vascular disease","volume":"128","author":"Conte","year":"2018","journal-title":"J Clin Invest"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-019-05638-y","article-title":"Serum and fecal oxylipins in patients with alcohol-related liver disease","volume":"64","author":"Gao","year":"2019","journal-title":"Dig Dis Sci"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.658840","article-title":"Resolution-based therapies: the potential of lipoxins to treat human diseases","volume":"12","author":"Jaen","year":"2021","journal-title":"Front Immunol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1021\/acsptsci.9b00097","article-title":"Therapeutic potential of lipoxin A(4) in chronic inflammation: focus on cardiometabolic disease","volume":"3","author":"Fu","year":"2020","journal-title":"ACS Pharmacol Transl Sci"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1186\/1476-511X-10-76","article-title":"Lipoxins as biomarkers of lupus and other inflammatory conditions","volume":"10","author":"Das","year":"2011","journal-title":"Lipids Health Dis"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00224.2003","article-title":"Lipoxins: endogenous regulators of inflammation","volume":"286","author":"McMahon","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pharmtox-051921-085014","article-title":"Structures of leukotriene biosynthetic enzymes and development of new therapeutics","volume":"63","author":"Haeggstrom","year":"2023","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2015.03.092","article-title":"Pro-resolving mediators produced from EPA and DHA: Overview of the pathways involved and their mechanisms in metabolic syndrome and related liver diseases","volume":"785","author":"Lopez-Vicario","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2016.00274","article-title":"Pathway markers for pro-resolving lipid mediators in maternal and umbilical cord blood: A secondary analysis of the mothers, omega-3, and mental health study","volume":"7","author":"Mozurkewich","year":"2016","journal-title":"Front Pharmacol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1042\/EBC20200018","article-title":"Specialized pro-resolving mediator network: an update on production and actions","volume":"64","author":"Chiang","year":"2020","journal-title":"Essays Biochem"},{"key":"B71","doi-asserted-by":"publisher","first-page":"18050","DOI":"10.1038\/s41598-018-36679-4","article-title":"Identification of specialized pro-resolving mediator clusters from healthy adults after intravenous low-dose endotoxin and omega-3 supplementation: a methodological validation","volume":"8","author":"Norris","year":"2018","journal-title":"Sci Rep"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2022.101597","article-title":"E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition","volume":"59","author":"Serhan","year":"2022","journal-title":"Semin Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.05.017","article-title":"The role of neutrophils in alcohol-related hepatitis","volume":"79","author":"Khan","year":"2023","journal-title":"J Hepatol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2020.08.015","article-title":"Eicosapentaenoic and docosahexaenoic acid derived specialised pro-resolving mediators: Concentrations in humans and the effects of age, sex, disease and increased omega-3 fatty acid intake","volume":"178","author":"Calder","year":"2020","journal-title":"Biochimie"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.10.023","article-title":"Inflammatory pathways in alcoholic steatohepatitis","volume":"70","author":"Gao","year":"2019","journal-title":"J Hepatol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1292\/jvms.16-0347","article-title":"Discovery of anti-inflammatory role of prostaglandin D(2)","volume":"78","author":"Murata","year":"2016","journal-title":"J Vet Med Sci"},{"key":"B77","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12931-018-0893-x","article-title":"The prostaglandin D(2) receptor 2 pathway in asthma: a key player in airway inflammation","volume":"19","author":"Domingo","year":"2018","journal-title":"Respir Res"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0676.2000.020002152.x","article-title":"Mast cell subpopulations in chronic inflammatory hepatobiliary diseases","volume":"20","author":"Matsunaga","year":"2000","journal-title":"Liver"},{"key":"B79","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1042\/bj2620195","article-title":"Cellular communication inside the liver. Binding, conversion and metabolic effect of prostaglandin D2 on parenchymal liver cells","volume":"262","author":"Kuiper","year":"1989","journal-title":"Biochem J"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28112","article-title":"Hepatic stellate cells relay inflammation signaling from sinusoids to parenchyma in mouse models of immune-mediated hepatitis","volume":"63","author":"Fujita","year":"2016","journal-title":"Hepatology"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2013.09.006","article-title":"The impact of obesity and metabolic syndrome on alcoholic liver disease","volume":"18","author":"Chiang","year":"2014","journal-title":"Clin Liver Dis"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510250120","article-title":"Excess weight risk factor for alcoholic liver disease","volume":"25","author":"Naveau","year":"1997","journal-title":"Hepatology"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/47.2.235","article-title":"Overweight as a risk factor or a predictive sign of histological liver damage in alcoholics","volume":"47","author":"Iturriaga","year":"1988","journal-title":"Am J Clin Nutr"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.03.046","article-title":"Obesity in acute alcoholic hepatitis increases morbidity and mortality","volume":"45","author":"Parker","year":"2019","journal-title":"EBioMedicine"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-327365","article-title":"A mechanism by which gut microbiota elevates permeability and inflammation in obese\/diabetic mice and human gut","volume":"72","author":"Mishra","year":"2023","journal-title":"Gut"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.833310","article-title":"Soluble immune checkpoints are dysregulated in COVID-19 and heavy alcohol users with HIV infection","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/agz036","article-title":"Alcoholic hepatitis: A review","volume":"54","author":"Hosseini","year":"2019","journal-title":"Alcohol Alcohol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01447","article-title":"Alox12\/15 deficiency exacerbates, while lipoxin A(4) ameliorates hepatic inflammation in murine alcoholic hepatitis","volume":"11","author":"Queck","year":"2020","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1377236\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:10:18Z","timestamp":1732147818000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1377236\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,21]]},"references-count":88,"alternative-id":["10.3389\/fimmu.2024.1377236"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1377236","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.12.15.23300034","asserted-by":"object"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,21]]},"article-number":"1377236"}}